EBMT-EHA CAR-T 2019 | Settings for CAR T-cell therapy
Erik Aerts
Erik Aertes, MD, PhD, from University Hospital Zurich, Zurich, Switzerland, discusses the differences in the use of CAR T-cell therapy between pediatric and adult patients. He highlights the different settings that CAR-T therapy can be given in (ambulatory or in-patient), as well as some of the challenges associated with this. This video was recorded at the 1st European CAR T-Cell Meeting in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).
Similar topics
Related videos

Toxicity issues with CAR T-cell therapy
Bianca Santomasso et al.

Post-transplant cyclophosphamide mechanisms
Christopher Kanakry

Optimal GVHD prophylaxis in T-cell repleted haploidentical transplantation
Christopher Kanakry

Transplant-associated thrombotic microangiopathy (TA-TMA)
Sergio Giralt

Donor type and source of choice
Leo Luznik
More from Erik Aerts